仅纳入已发表数据的系统评价可能高估腰痛镇痛药疗效
该研究检索试验注册库中符合5项源系统评价纳入标准的未发表数据,复现并更新meta分析。结果发现,加入未发表数据后,肌肉松弛剂对近期腰痛的效果量从-21.71降至-2.34(0-100分),阿片类对慢性腰痛的效果量从-10.10降至-9.31。提示系统评价应纳入未发表试验报告。
要点
- 仅用已发表数据可能高估肌肉松弛剂对近期腰痛的疗效。
- 纳入未发表数据后阿片类对慢性腰痛效果小且可能无临床意义。
- 系统评价应检索并纳入试验注册库中的未发表数据。
核心结论
- 系统评价应纳入未发表试验报告,仅用已发表数据可能高估疗效。
- 肌肉松弛剂结果与已发表系统评价及近期国际指南结论冲突。
- 未发表数据强化阿片类对慢性腰痛效果小的证据,提示可能无临床意义。
研究设计与样本
- 检索试验注册库,寻找符合5项源系统评价纳入标准的未发表数据。
- 用源系统评价已发表数据复现meta分析,再加入未发表数据重跑分析。
- 16项已完成未发表试验符合4项源评价纳入标准,其中5项试验有数据。
- 更新了2项源系统评价的分析。
主要发现
- 加入2项试验数据后,肌肉松弛剂对比假针对近期腰痛的效果量从-21.71(95%CI:-28.23至-15.19)变为-2.34(95%CI:-3.34至-1.34),疼痛强度0-100分。
- 加入3项试验(含1项富集设计)后,阿片类对比假针对慢性腰痛的效果量从-10.10(95%CI:-12.81至-7.39)变为-9.31(95%CI:-11.51至-7.11)。
- 富集设计亚组效果量从-12.40(95%CI:-16.90至-7.91)变为-11.34(95%CI:-15.36至-7.32)。
- 非富集设计亚组效果量从-7.27(95%CI:-9.97至-4.57)变为-7.19(95%CI:-9.24至-5.14)。
临床怎么用
- 开展腰痛镇痛药系统评价时应检索试验注册库并纳入未发表数据。
- 解读肌肉松弛剂疗效时需注意未发表数据可能显著改变效果量。
- 阿片类对慢性腰痛的效果可能很小且无临床意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Systematic reviews of analgesics for low back pain generally include published data only. Obtaining data from unpublished trials is potentially important because they may impact effect sizes in meta-analyses. We determined whether including unpublished data from trial registries changes the effect sizes in meta-analyses of analgesics for low back pain. STUDY DESIGN AND SETTING: Trial registries were searched for unpublished data that conformed to the inclusion criteria of n = 5 individual source systematic reviews. We reproduced the meta-analyses using data available from the original reviews and then reran the same analyses with the addition of new unpublished data. RESULTS: Sixteen completed, unpublished, trials were eligible for inclusion in four of the source reviews. Data were available for five trials. We updated the analyses for two of the source reviews. The addition of data from two trials reduced the effect size of muscle relaxants, compared with sham, for recent-onset low back pain from -21.71 (95% CI: -28.23 to -15.19) to -2.34 (95% CI: -3.34 to -1.34) on a 0-100 scale for pain intensity. The addition of data from three trials (one enriched design) reduced the effect size of opioid analgesics, compared with sham, for chronic low back pain from -10.10 (95% CI: -12.81 to -7.39) to -9.31 (95% CI: -11.51 to -7.11). The effect reduced in the subgroup of enriched design studies, from -12.40 (95% CI: -16.90 to -7.91) to -11.34 (95% CI: -15.36 to -7.32), and in the subgroup of nonenriched design studies, from -7.27 (95% CI: -9.97 to -4.57) to -7.19 (95% CI: -9.24 to -5.14). CONCLUSION: Systematic reviews should include reports of unpublished trials. The result for muscle relaxants conflicts with the conclusion of the published review and recent international guidelines. Adding unpublished data strengthens the evidence that opioid analgesics have small effects on persistent low back pain and more clearly suggests these effects may not be clinically meaningful.
引用
- Bagg MK, O'Hagan E, Zahara P, et al. Systematic reviews that include only published data may overestimate the effectiveness of analgesic medicines for low back pain: a systematic review and meta-analysis. J Clin Epidemiol. 2019. PMID: 31816418. doi:10.1016/j.jclinepi.2019.12.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。